Erudio Healtherudio.com
Drug
Rilvegostomig trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying rilvegostomig: ARTEMIDE-01. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 8 more trials with public commentary and no report yet.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| ARTEMIDE-01 NCT04995523 · AstraZeneca | advanced or metastatic NSCLC | Phase 1/Phase 2 | 53 | 15 | Focused | Oct 29, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| NeoCOAST-2 NCT05061550 · AstraZeneca DeepView → | resectable stage II–IIIB non-small cell lung cancer | Phase 2 | Deep | View | |||
| DESTINY-Gastric03 NCT04379596 · AstraZeneca DeepView → | advanced HER2-expressing gastric cancer | Phase 2 | Deep | View | |||
| TROPION-Lung04 NCT04612751 · AstraZeneca DeepView → | advanced or metastatic non-small cell lung cancer | Phase 1 | Deep | View | |||
| DESTINY-Lung03 NCT04686305 · AstraZeneca DeepView → | first-line advanced or metastatic HER2-overexpressing non-squamous NSCLC | Phase 1 | Deep | View | |||
| DESTINY-BTC01 NCT06467357 · AstraZeneca StandardView → | first-line HER2-expressing advanced biliary tract cancer | Phase 3 | Standard | View | |||
| ARTEMIDE-Gastric01 NCT06764875 · AstraZeneca StandardView → | first-line HER2-positive gastric or gastroesophageal junction cancer | Phase 3 | Standard | View | |||
| TROPION-PanTumor03 NCT05489211 · AstraZeneca FocusedView → | advanced/metastatic solid tumors | Phase 2 | Focused | View | |||
| TROPION-Urothelial04 NCT07720284 · AstraZeneca FocusedView → | Not given | Phase 3 | Focused | View | |||